리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 09월
페이지 정보:영문 378 Pages
라이선스 & 가격 (부가세 별도)
한글목차
모바일 심장 텔레메트리 세계 시장 규모는 2030년까지 16억 달러에 달할 것으로 예상됩니다
2023년 9억 7,670만 달러로 추정되는 모바일 심장 텔레메트리 세계 시장은 2023-2030년의 분석 기간 동안 연평균 6.9% 성장하여 2030년에는 16억 달러에 이를 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 협심증 적응증은 CAGR 8.6%를 기록하여 분석 기간 종료 시점에 5억 6,270만 달러에 도달할 것으로 예상됩니다. 관상동맥 질환 적응증 부문의 성장률은 분석 기간 동안 CAGR 6.8%로 추정됩니다.
미국 시장은 약 2억 6,610만 달러, 중국은 CAGR 11.3%로 성장할 것으로 예상
미국의 모바일 심장 텔레메트리 시장은 2023년 2억 6,610만 달러에 달할 것으로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 3억 4,750만 달러 규모에 도달할 것으로 예상되며, 분석 기간인 2023-2030년 동안 11.3%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.9%와 6.9%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 4.4%의 성장률을 보일 것으로 예상됩니다.
세계 모바일 심장 텔레메트리 시장 - 주요 동향 및 촉진요인 요약
모바일 심장 텔레메트리이란 무엇이며, 왜 중요한가?
모바일 심장 원격 측정(MCT) 시스템은 환자의 심장 활동을 실시간으로 지속적으로 관찰할 수 있는 심장 모니터링의 중요한 발전입니다. 제한된 기간 동안 데이터를 기록하고 데이터 분석을 위해 환자가 클리닉으로 돌아와야 하는 기존 홀터 모니터와 달리 MCT 시스템은 모바일 네트워크를 통해 ECG 데이터를 의료 서비스 제공업체에게 직접 전송합니다. MCT 시스템의 핵심 요구사항은 특히 고위험군 환자나 표준 진료실 평가에서 포착할 수 없는 일시적인 심장 증상을 경험하는 환자들에게 적합한 적시에 정확하고 실용적인 데이터를 제공하는 능력에 있습니다. 증상을 경험하는 환자들에게 특히 적합합니다. 이 기술은 심방세동, 심실빈맥, 기타 부정맥과 같이 신속히 발견하고 치료하지 않으면 심각한 또는 치명적인 결과를 초래할 수 있는 질환을 진단하는 데 특히 중요합니다. 또한, MCT 시스템은 가볍고 착용이 가능하며 침습적이지 않아 환자의 순응도와 편안함을 향상시켜 일상 생활에 지장을 주지 않고 일상생활을 영위할 수 있도록 돕습니다.
기술은 MCT 시스템의 효과를 어떻게 향상시킬 수 있는가?
모바일 심장 텔레메트리을 뒷받침하는 기술은 첨단 바이오센서, 모바일 연결, 클라우드 기반 분석을 고도로 융합한 것으로, MCT 장치에는 일반적으로 심장의 전기적 활동을 포착하는 전극, 이 데이터를 실시간으로 중앙 모니터링 스테이션으로 전송하는 송신기, 그리고 정보를 분석하는 소프트웨어가 포함되어 있습니다. 실시간으로 중앙 모니터링 스테이션으로 전송하는 송신기, 이상 유무를 분석하는 소프트웨어가 포함됩니다. 인공지능(AI)과 머신러닝 알고리즘의 통합은 MCT 시스템의 효율성을 더욱 높이고 있습니다. 이러한 알고리즘은 불규칙한 심장 박동 패턴을 신속하게 식별할 수 있어 의료 서비스 제공업체에게 조기 경보 시스템을 제공합니다. 또한, 대규모 데이터 세트를 장기간 저장하고 분석할 수 있는 능력은 추세와 패턴을 식별하고 더 많은 정보에 입각한 임상적 판단을 내릴 수 있어 환자 결과를 개선할 수 있습니다. 데이터 전송의 안정성과 최신 모바일 네트워크의 낮은 지연 시간으로 인해 심장 기능의 미세한 편차도 확실하게 감지하고 의료 전문가에게 신속하게 전달할 가능성이 있습니다.
MCT 시스템 도입에 있어 소비자 행동은 어떤 역할을 하는가?
소비자 행동과 환자 참여는 모바일 심장 텔레메트리의 보급에 있어 점점 더 중요한 역할을 하고 있습니다. 환자가 자신의 건강에 대해 보다 적극적으로 정보를 얻게 되면서 편리성, 정확성, 안심할 수 있는 모니터링 솔루션에 대한 수요가 증가하고 있으며, 코로나19 팬데믹으로 인해 가속화되고 있는 원격 의료 및 원격 의료 서비스로의 전환은 MCT와 같은 기술의 중요성을 더욱 부각시키고 있습니다. 기술의 중요성을 더욱 부각시키고 있습니다. 환자들은 이제 웨어러블 기기에 익숙해졌고, 전반적인 치료 전략의 일환으로 실시간 건강 모니터링을 기대하고 있습니다. 또한 MCT 시스템의 사용 편의성과 비침습성은 기존 모니터링 방법을 싫어하는 고령 환자들을 포함한 더 많은 환자들에게 어필하고 있습니다. 스마트폰 및 기타 개인용 기기와 원활하게 통합할 수 있다는 점도 MCT 시스템의 매력에 기여하고 있습니다. 환자들은 자신의 건강 지표를 쉽게 추적하고 의료진과 데이터를 공유할 수 있어 보다 개인화된 치료를 받을 수 있습니다.
MCT 시장 성장을 가속하는 요인은 무엇인가?
모바일 심장 원격 측정(Mobile Cardiac Telemetry) 시장의 성장은 헬스케어와 기술의 진화를 반영하는 몇 가지 요인에 의해 주도되고 있습니다. 주요 촉진요인 중 하나는 전 세계적으로 심혈관 질환의 유병률이 증가하고 있으며, 특히 부정맥 및 기타 심장 질환의 위험이 높은 고령화 사회에서 증가를 들 수 있습니다. 또한 비만, 당뇨병, 고혈압 등 심장병과 밀접한 관련이 있는 생활습관병의 발병률이 증가함에 따라 MCT와 같은 지속적인 모니터링 솔루션의 필요성이 증가하고 있으며, 4G 및 5G 네트워크의 확장을 포함한 모바일 기술의 발전은 MCT 시스템의 실시간 기능에 필수적인 더 빠르고 신뢰할 수 있는 MCT 시스템의 실시간 기능에 필수적인 보다 빠르고 안정적인 데이터 전송을 가능하게 함으로써 중요한 역할을 하고 있습니다. 또한 예방 의료와 조기 진단에 대한 관심이 높아지면서 의료진과 환자 모두 MCT 시스템을 심장 치료의 표준으로 채택하고 있습니다. 일부 지역의 규제 지원과 유리한 상환 정책은 시장 성장을 더욱 촉진하고 MCT 시스템을 더 많은 환자들이 쉽게 이용할 수 있도록 돕고 있습니다. 마지막으로, 보다 정교하고 사용하기 쉬운 기기의 출시로 새로운 사용자가 계속 증가하고 있어 모바일 심장 텔레메트리 시장은 향후 몇 년동안 지속적으로 확대될 것으로 예상됩니다.
조사 대상 기업 예시(총 42건)
ACS Diagnostics, Inc.
Baxter International Inc.
BioTelemetry, Inc.
Biotricity Inc.
Boston Scientific Cardiac Diagnostics Inc.
Comarch SA
GE Healthcare
Infinium Medical, Inc.
iRhythm Technologies, Inc.
LifeSignals, Inc.
Medtronic PLC
Philips Healthcare USA
ScottCare Cardiovascular Solutions
Telerhythmics, LLC
Zoll Medical Corporation
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
LSH
영문 목차
영문목차
Global Mobile Cardiac Telemetry Systems Market to Reach US$1.6 Billion by 2030
The global market for Mobile Cardiac Telemetry Systems estimated at US$976.7 Million in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Angina Pectoris Indication, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$562.7 Million by the end of the analysis period. Growth in the Coronary Artery Diseases Indication segment is estimated at 6.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$266.1 Million While China is Forecast to Grow at 11.3% CAGR
The Mobile Cardiac Telemetry Systems market in the U.S. is estimated at US$266.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$347.5 Million by the year 2030 trailing a CAGR of 11.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
Global Mobile Cardiac Telemetry Systems Market - Key Trends and Drivers Summarized
What Are Mobile Cardiac Telemetry Systems and Why Are They Critical?
Mobile Cardiac Telemetry (MCT) systems represent a significant advancement in cardiac monitoring, providing real-time, continuous observation of a patient's heart activity. Unlike traditional Holter monitors, which record data for a limited period and require the patient to return to the clinic for data analysis, MCT systems transmit ECG data directly to healthcare providers via mobile networks. This allows for immediate detection and intervention in cases of arrhythmias or other cardiac events. The critical need for MCT systems lies in their ability to provide timely, accurate, and actionable data, especially for high-risk patients or those experiencing transient cardiac symptoms that might not be captured during a standard in-office evaluation. This technology is particularly crucial for diagnosing conditions like atrial fibrillation, ventricular tachycardia, and other arrhythmias, which can have serious or fatal outcomes if not promptly identified and treated. Additionally, MCT systems enhance patient compliance and comfort, as they are lightweight, wearable, and minimally invasive, enabling patients to go about their daily activities without interruption.
How Does Technology Elevate The Effectiveness of MCT Systems?
The technology behind Mobile Cardiac Telemetry systems is a sophisticated blend of advanced biosensors, mobile connectivity, and cloud-based analytics. MCT devices typically include electrodes that capture the heart's electrical activity, a transmitter that sends this data in real-time to a central monitoring station, and software that analyzes the information for any abnormalities. The integration of artificial intelligence (AI) and machine learning algorithms has further elevated the effectiveness of MCT systems. These algorithms can quickly identify irregular patterns in heartbeats, providing an early warning system for healthcare providers. Furthermore, the ability to store and analyze large datasets over time allows for better patient outcomes, as trends and patterns can be identified, leading to more informed clinical decisions. The reliability of data transmission and the low latency of modern mobile networks ensure that even the slightest deviation in heart function is detected and communicated to medical professionals promptly.
What Role Does Consumer Behavior Play in The Adoption of MCT Systems?
Consumer behavior and patient engagement are playing increasingly vital roles in the widespread adoption of Mobile Cardiac Telemetry systems. As patients become more informed and proactive about their health, there is a growing demand for monitoring solutions that offer convenience, accuracy, and peace of mind. The shift toward telemedicine and remote healthcare services, accelerated by the COVID-19 pandemic, has further highlighted the importance of technologies like MCT. Patients are now more comfortable with wearable devices and expect real-time health monitoring as part of their overall care strategy. Additionally, the ease of use and non-invasive nature of MCT systems appeal to a broader demographic, including elderly patients who might be averse to traditional monitoring methods. The ability of these systems to integrate seamlessly with smartphones and other personal devices also contributes to their appeal, as patients can easily track their own health metrics and share data with their healthcare providers, leading to more personalized care.
What Factors Are Driving The Growth of The MCT Market?
The growth in the Mobile Cardiac Telemetry market is driven by several factors that reflect the evolving landscape of healthcare and technology. One of the primary drivers is the increasing prevalence of cardiovascular diseases globally, particularly in aging populations where the risk of arrhythmias and other heart conditions is higher. Additionally, the rising incidence of lifestyle-related conditions, such as obesity, diabetes, and hypertension, which are closely linked to heart disease, has amplified the need for continuous monitoring solutions like MCT. Advances in mobile technology, including the expansion of 4G and 5G networks, have also played a crucial role by enabling faster and more reliable data transmission, which is essential for the real-time capabilities of MCT systems. Moreover, the growing focus on preventive healthcare and early diagnosis is pushing both healthcare providers and patients toward adopting MCT systems as a standard part of cardiac care. Regulatory support and favorable reimbursement policies in several regions have further bolstered market growth, making these systems more accessible to a wider patient base. Lastly, the ongoing development of more sophisticated and user-friendly devices continues to attract new users, ensuring that the market for Mobile Cardiac Telemetry systems will expand in the coming years.
Select Competitors (Total 42 Featured) -
ACS Diagnostics, Inc.
Baxter International Inc.
BioTelemetry, Inc.
Biotricity Inc.
Boston Scientific Cardiac Diagnostics Inc.
Comarch SA
GE HealthCare
Infinium Medical, Inc.
iRhythm Technologies, Inc.
LifeSignals, Inc.
Medtronic PLC
Philips Healthcare USA
ScottCare Cardiovascular Solutions
Telerhythmics, LLC
Zoll Medical Corporation
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Mobile Cardiac Telemetry Systems - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Advancements in Mobile and Wireless Technologies Propel Growth in Mobile Cardiac Telemetry Systems
Rising Incidence of Cardiovascular Diseases Expands Addressable Market Opportunity for MCT
Integration of AI and Predictive Analytics Strengthens the Business Case for Real-Time Cardiac Monitoring
Increasing Shift Towards Remote Patient Monitoring Drives Adoption of Mobile Cardiac Telemetry
Technological Innovations in Wearable Devices Spur Growth in Continuous Heart Monitoring Solutions
Growing Awareness of Preventive Healthcare Generates Demand for Early Detection Tools
Emerging Markets and Aging Populations Create New Growth Avenues for MCT Systems
Challenges in Data Security and Privacy Create Opportunities for Innovation in Secure MCT Systems
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Mobile Cardiac Telemetry Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Angina Pectoris by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Angina Pectoris by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Angina Pectoris by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Coronary Artery Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Coronary Artery Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Coronary Artery Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Atherosclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Atherosclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Atherosclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Heart Failure & Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Heart Failure & Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Heart Failure & Stroke by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Cardiac Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Cardiac Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Cardiac Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Lead-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Lead-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Lead-based Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Patch-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Patch-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Patch-based Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
CANADA
TABLE 44: Canada Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
JAPAN
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 53: Japan Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
CHINA
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 62: China Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 65: China Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
EUROPE
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 71: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
FRANCE
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 83: France Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 86: France Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
GERMANY
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 92: Germany Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 95: Germany Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
ITALY
TABLE 101: Italy Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 104: Italy Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
UNITED KINGDOM
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 110: UK Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 113: UK Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
SPAIN
TABLE 119: Spain Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: Spain Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: Spain 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 122: Spain Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: Spain Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: Spain 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 125: Spain Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Spain Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Spain 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
RUSSIA
TABLE 128: Russia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: Russia Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Russia 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 131: Russia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Russia Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Russia 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 134: Russia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Russia Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Russia 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Europe Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of Europe Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of Europe Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 147: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
AUSTRALIA
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 158: Australia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Australia Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Australia 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 161: Australia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Australia Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Australia 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 164: Australia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: Australia Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Australia 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
INDIA
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 167: India Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: India Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: India 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 170: India Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: India Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: India 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 173: India Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: India Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: India 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 176: South Korea Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: South Korea Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: South Korea 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 179: South Korea Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: South Korea Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: South Korea 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 182: South Korea Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: South Korea Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: South Korea 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Rest of Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: Rest of Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
LATIN AMERICA
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 194: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 195: Latin America Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 197: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 200: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Latin America Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 203: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 206: Argentina Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Argentina Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Argentina 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 209: Argentina Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 210: Argentina Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 211: Argentina 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 212: Argentina Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 213: Argentina Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 214: Argentina 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
BRAZIL
TABLE 215: Brazil Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 216: Brazil Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 217: Brazil 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 218: Brazil Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 219: Brazil Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 220: Brazil 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 221: Brazil Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 222: Brazil Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 223: Brazil 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
MEXICO
TABLE 224: Mexico Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 225: Mexico Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 226: Mexico 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 227: Mexico Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 228: Mexico Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 229: Mexico 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 230: Mexico Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 231: Mexico Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 232: Mexico 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 234: Rest of Latin America Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 235: Rest of Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 237: Rest of Latin America Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 238: Rest of Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 240: Rest of Latin America Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 241: Rest of Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
MIDDLE EAST
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 242: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 243: Middle East Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 244: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 245: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 247: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 248: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 249: Middle East Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 250: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 251: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 253: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
IRAN
TABLE 254: Iran Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 255: Iran Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 256: Iran 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 257: Iran Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 258: Iran Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 259: Iran 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 260: Iran Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 261: Iran Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 262: Iran 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
ISRAEL
TABLE 263: Israel Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 264: Israel Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 265: Israel 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 266: Israel Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 267: Israel Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 268: Israel 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 269: Israel Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 270: Israel Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 271: Israel 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 273: Saudi Arabia Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 274: Saudi Arabia 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 276: Saudi Arabia Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 277: Saudi Arabia 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 279: Saudi Arabia Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 280: Saudi Arabia 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 281: UAE Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 282: UAE Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 283: UAE 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 284: UAE Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 285: UAE Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 286: UAE 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 287: UAE Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 288: UAE Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 289: UAE 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 291: Rest of Middle East Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 292: Rest of Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 294: Rest of Middle East Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 295: Rest of Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 297: Rest of Middle East Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 298: Rest of Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
AFRICA
Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 299: Africa Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 300: Africa Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 301: Africa 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
TABLE 302: Africa Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 303: Africa Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 304: Africa 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
TABLE 305: Africa Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 306: Africa Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 307: Africa 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030